Parallax Volatility Advisers, L.P. Aurinia Pharmaceuticals Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$4.81 - $5.78 $125,059 - $150,280	26,000 Added 866.67%	29,000 $165,000
Q1 2024 May 15, 2024	BUY	$4.93 - $9.31 $14,790 - $27,930	3,000 New	3,000 $15,000
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $5,376 - $7,014	600 New	600 $5,000
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $606,298 - $1.13 Million	-34,100 Reduced 53.12%	30,100 $688,000
Q3 2021 Nov 15, 2021	BUY	$10.93 - $23.55 $701,706 - $1.51 Million	64,200 New	64,200 $1.42 Million
Q4 2017 Feb 14, 2018	SELL	$4.53 - $7.09 $226,500 - $354,500	-50,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.71 - $6.9 $285,500 - $345,000	50,000	50,000 $314,000

208

58.6M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.29B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.